GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurora Cannabis Inc (TSX:ACB) » Definitions » Capex-to-Revenue

Aurora Cannabis (TSX:ACB) Capex-to-Revenue : 0.04 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Aurora Cannabis Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Aurora Cannabis's Capital Expenditure for the three months ended in Dec. 2023 was C$-2.79 Mil. Its Revenue for the three months ended in Dec. 2023 was C$64.42 Mil.

Hence, Aurora Cannabis's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.04.


Aurora Cannabis Capex-to-Revenue Historical Data

The historical data trend for Aurora Cannabis's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Cannabis Capex-to-Revenue Chart

Aurora Cannabis Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.42 2.48 1.69 1.30 0.22

Aurora Cannabis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.06 0.06 0.07 0.04

Competitive Comparison of Aurora Cannabis's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurora Cannabis's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aurora Cannabis's Capex-to-Revenue falls into.



Aurora Cannabis Capex-to-Revenue Calculation

Aurora Cannabis's Capex-to-Revenue for the fiscal year that ended in Jun. 2021 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-53.082) / 245.252
=0.22

Aurora Cannabis's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.787) / 64.419
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurora Cannabis  (TSX:ACB) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Aurora Cannabis Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aurora Cannabis's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurora Cannabis (TSX:ACB) Business Description

Traded in Other Exchanges
Address
3498 63 Avenue, Leduc, AB, CAN, T9E 0G8
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Executives
Andre Jerome Senior Officer
Alex Miller Senior Officer
Lori Schick Senior Officer

Aurora Cannabis (TSX:ACB) Headlines

From GuruFocus

Aurora Introduces Fresh Innovation for Spring

By PRNewswire PRNewswire 04-25-2023